advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions research hub

Ramucirumab plus Irinotecan / Leucovorin / 5-FU versus Ramucirumab plus Paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy - The Phase II/III RAMIRIS STUDY

This study is looking at new ways to treat stomach or food pipe cancer that has spread or come back, after initial chemotherapy hasn't worked. It compares two different combinations of medicines to see which is more effective at helping people live longer and shrinking their cancer.